OpGen Inc (OTCPK:OPGN)
$ 0.6375 0.018125 (2.93%) Market Cap: 6.42 Mil Enterprise Value: 6.84 Mil PE Ratio: 0 PB Ratio: 2.13 GF Score: 40/100

Q2 2020 OpGen Inc Earnings Call Transcript

Aug 12, 2020 / 08:30PM GMT
Release Date Price: $522 (+1.95%)
Operator

Greetings, and welcome to the OpGen, Inc. conference call. (Operator Instructions) It is now my pleasure to introduce your host, Megan Paul, Investor Relations. Please go ahead.

Megan Paul

Welcome to the OpGen Second Quarter 2020 Earnings Call and Business update. (Operator Instructions) Following management's prepared remarks, there will be a Q&A session. As a reminder, this conference call is being recorded today, August 12, 2020.

Before we begin, I would like to caution you that comments made during this conference call by management may contain forward-looking statements regarding the operations of and future results of OpGen, including its subsidiary Acuitas and Ares Genetics. I encourage you to review OpGen's filings with the Securities and Exchange Commission, including, without limitation, the company's most recent Form 10-K and Form 10-Q in the second quarter of 2020, that will be filed with the SEC, which identifies specific factors that may cause actual results or events to differ materially from those described in the forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot